Investigating Hereditary Cardiac Disease by Reprogramming Skin Cells to Heart Muscle
NCT ID: NCT01865981
Last Updated: 2020-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2 participants
OBSERVATIONAL
2013-06-30
2017-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of the study is that the differentiated cardiac cells will display electrical abnormalities dependent on the mutation causing the disease. These abnormalities can therefore provide a clue as to the nature of the mutation causing the disease or information about its effective management
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells
NCT01734356
Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
NCT00221832
Cardiac Resynchronization Therapy in Congenital Heart Defects
NCT00450684
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
NCT06575881
Ventricular Tachycardia Mechanisms
NCT05478213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hereditary VF
Patients with hereditary ventricular fibrillation, negative for known mutations
No interventions assigned to this group
Brugada
Patients suffering from Brugada syndrome
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mutation positive or mutation negative
* Idiopathic ventricular fibrillation
Exclusion Criteria
* Age less than 18 years
* clinical diagnosis ambiguous
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Dundee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marios P Stavridis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Dundee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Dundee
Dundee, Angus, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T13/21
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2012CA04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.